Use of [89Zr]Zr-Df-IAB22M2C CD8 PET for Directing Solid Tumor Biopsies to Assess the Immune Status Within the Tumor Microenviroment (TME)

被引：0
|
作者：
Hays, D. [1 ]
St Amour, E. [1 ]
Randall, C. [1 ]
Wilson, I. [2 ]
Le, W. [2 ]
Korn, R. [3 ]
机构：
[1] CARTI Canc Ctr, Little Rock, AR USA
[2] ImaginAb Inc, Inglewood, CA USA
[3] Imaging Endpoints, Scottsdale, AZ USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0645
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 23 条
  • [1] [89Zr]Zr-Df-IAB22M2C in metastatic cancer
    Geraldes, Flavia Oliveira
    LANCET ONCOLOGY, 2021, 22 (12): : 1655 - 1655
  • [2] Dose Reduction Strategies for Optimizing [89ZR]Zr-Df-IAB22M2C PET Scans Using Virtual Reconstruction (VR) Techniques
    Korn, R.
    Abbott, A.
    Sunderland, J.
    Wilson, I.
    Le, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S492 - S493
  • [3] In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRI
    Schwenck, Johannes
    Sonanini, Dominik
    Seyfried, Dominik
    Ehrlichmann, Walter
    Kienzle, Gabriele
    Reischl, Gerald
    Krezer, Pascal
    Wilson, Ian
    Korn, Ron
    Gonzalez-Menendez, Irene
    Quintanilla-Martinez, Leticia
    Seith, Ferdinand
    Forschner, Andrea
    Eigentler, Thomas
    Zender, Lars
    Roecken, Martin
    Pichler, Bernd J.
    Flatz, Lukas
    Kneilling, Manfred
    la Fougere, Christian
    THERANOSTICS, 2023, 13 (08): : 2408 - 2423
  • [4] Optimization of 89Zr PET imaging using both phantom and clinical studies with [89Zr]-Df-IAB22M2C, an anti-CD8 minibody
    Daube-Witherspoon, Margaret
    Farwell, Michael
    Sunderland, John
    Viswanath, Varsha
    Korn, Ronald
    Wilson, Ian
    Karp, Joel
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [5] CD8 Positron Emission Tomography (PET/CT) Imaging with 89Zr-Df-IAB22M2C in Patients with Inclusion Body Myositis
    Quinn, Colin
    Moulton, Kelsey
    Korn, Ron
    Le, William
    Goel, Niti
    Farwell, Michael
    Greenberg, Steven
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1427 - 1429
  • [6] A phase II, open-label, multi-dose study of [89Zr]Zr-Df-IAB22M2C (CD8 cell PET tracer) PET/CT in patients with selected advanced or metastatic solid malignancies scheduled to receive standard of care immunotherapy, as single agent or in combination
    Margolin, K. A.
    Korn, R.
    Farwell, M.
    Postow, M. A.
    Hays, D.
    Wilson, I. A.
    Le, W. H.
    ANNALS OF ONCOLOGY, 2021, 32 : S930 - S930
  • [7] CD8 PET IMAGING OF TUMOR INFILTRATING T CELLS IN ADVANCED SOLID TUMORS: A PHASE I FIRST-INHUMAN STUDY OF 89ZR-IAB22M2C, A RADIOLABELED ANTI-CD8 MINIBODY
    Farwell, Michael
    Gamache, Raymond
    Pandit-Taskar, Neeta
    Postow, Mike
    Gordon, Michael
    Wilson, Ian
    Mascioni, Alessandro
    Wu, Anna
    Le, William
    Weiss, Avital
    Korn, Ronald
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A179 - A180
  • [8] Preclinical development of ZED8, an 89Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
    Ogasawara, Annie
    Kiefer, James R.
    Gill, Herman
    Chiang, Eugene
    Sriraman, Shravan
    Ferl, Gregory Z.
    Ziai, James
    Bohorquez, Sandra Sanabria
    Guelman, Sebastian
    Wang, Xiangdan
    Yang, Jihong
    Phan, Minh Michael
    Van Nguyen
    Chung, Shan
    Yu, Christine
    Tinianow, Jeff
    Waaijer, Stijn Jan Hein
    De Crespigny, Alex
    Marik, Jan
    Boswell, C. Andrew
    Zabka, Tanja
    Staflin, Karin
    Williams, Simon-Peter
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (02) : 287 - 301
  • [9] Correction to: Preclinical development of ZED8, an 89Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
    Annie Ogasawara
    James R. Kiefer
    Herman Gill
    Eugene Chiang
    Shravan Sriraman
    Gregory Z. Ferl
    James Ziai
    Sandra Sanabria Bohorquez
    Sebastian Guelman
    Xiangdan Wang
    Jihong Yang
    Minh Michael Phan
    Van Nguyen
    Shan Chung
    Christine Yu
    Jeff Tinianow
    Stijn Jan Hein Waaijer
    Alex De Crespigny
    Jan Marik
    C. Andrew Boswell
    Tanja Zabka
    Karin Staflin
    Simon‑Peter Williams
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 631 - 631
  • [10] Preclinical development of ZED8, an 89Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
    Annie Ogasawara
    James R. Kiefer
    Herman Gill
    Eugene Chiang
    Shravan Sriraman
    Gregory Z. Ferl
    James Ziai
    Sandra Sanabria Bohorquez
    Sebastian Guelman
    Xiangdan Wang
    Jihong Yang
    Minh Michael Phan
    Van Nguyen
    Shan Chung
    Christine Yu
    Jeff Tinianow
    Stijn Jan Hein Waaijer
    Alex De Crespigny
    Jan Marik
    C. Andrew Boswell
    Tanja Zabka
    Karin Staflin
    Simon-Peter Williams
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 287 - 301
123